StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ACET

Adicet Bio, Inc.

ACET Nasdaq Pharmaceutical Preparations EDGAR ↗
$9.21
-0.03 -0.32%

Key statistics

from XBRL data in SEC filings
Market cap
$86.1M
Revenue (TTM)
Net income (TTM)
-$109M
EPS (TTM)
$-13.87
P/E ratio
Dividend yield
Free cash flow
-$97.0M
Cash
$36.2M
Total assets
$169M
Gross margin
52-week range
$6.01 – $17.44

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 18, 2026 10-K/A Fiscal year ended 2025-12-31 May 20, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Unregistered sale of equity Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Regulation FD disclosure; Other events Jan 7, 2026 8-K Amended charter or bylaws; Other events Dec 29, 2025 8-K Shareholder vote results Dec 19, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Delisting notice or listing-rule failure Oct 7, 2025 8-K Entered a material agreement Oct 7, 2025 8-K Other events Oct 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Exit or disposal costs; Other events Jul 23, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Director or officer change; Regulation FD disclosure Apr 17, 2025 8-K Delisting notice or listing-rule failure Apr 11, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Other events Feb 5, 2025 8-K Regulation FD disclosure; Other events Dec 19, 2024 8-K Terminated a material agreement Nov 27, 2024 8-K Regulation FD disclosure; Other events Nov 18, 2024 8-K Entered a material agreement Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Regulation FD disclosure; Other events Oct 16, 2024 8-K Regulation FD disclosure; Other events Sep 30, 2024 8-K Regulation FD disclosure; Other events Sep 19, 2024 8-K Other events Sep 10, 2024 8-K Director or officer change; Regulation FD disclosure Aug 19, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Regulation FD disclosure Jul 8, 2024